Development of a pharmacokinetic/pharmacodynamic/disease progression model in NC/Nga mice for development of novel anti-atopic dermatitis drugs

References

• Arshad SH. (2005). Primary prevention of asthma and allergy. J Allergy Clin Immunol 116:3–14
   PubMed Web of Science ®Google Scholar
• Avdeef A. (1993). pH-metric log P. II: refinement of partition coefficients and ionization constants of multiprotic substances. J Pharm Sci 82:183–90
   PubMed Web of Science ®Google Scholar
• Baek IH, Chae JW, Song GY, Kwon KI. (2009). LC-MS/MS assay validation for a new immune modulator, JHL45, and its major metabolite in plasma: application to pharmacokinetic studies in rats. Bull Korea Chem Soc 30:2631–6
   Web of Science ®Google Scholar
• Blume-Peytavi U, Wahn U. (2011). Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate. J Eur Acad Dermatol Venereol 25:508–15
   PubMedGoogle Scholar
• Buddenkotte J, Steinhoff M. (2010). Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 65:805–21
   PubMedGoogle Scholar
• Chan PL, Holford NH. (2011). Drug treatment effects on disease progression. Annu Rev Pharmacol Toxicol 41:625–59
   Google Scholar
• D’Argenio DZ, Schumitzky A, Wang X. (2009). ADAPT 5 user’s guide: pharmacokinetic/pharmacodynamic systems analysis software. Los Angeles: Biomedical Simulations Resource
   Google Scholar
• Dayneka NL, Garg V, Jusko WJ. (1993). Comparison of four basic models of indirect pharmacodynamics responses. J Pharmacokinet Biopharm 21:457–78
   PubMedGoogle Scholar
• Di L, Kerns EH. (2003). Profiling drug-like properties in discovery research. Curr Opin Chem Biol 7:402–8
   PubMed Web of Science ®Google Scholar
• Dunstan JA, Brothers S, Bauer J, et al. (2011). The effects of Mycobacteria vaccae derivative on allergen-specific responses in children with atopic dermatitis. Clin Exp Immunol 164:321–9
   PubMedGoogle Scholar
• Furue M, Chiba T, Takeuchi S. (2011). Current status of atopic dermatitis in Japan. Asia Pac Allergy 1:64–72
   PubMedGoogle Scholar
• Gao F, Johnson DL, Ekins S, et al. (2002). Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC50. J Biomol Screen 7:373–82
   PubMed Web of Science ®Google Scholar
• Godfrey KR, Arundel PA, Dong Z, Bryant R. (2011). Modelling the double peak phenomenon in pharmacokinetics. Comput Methods Programs Biomed 104:62–9
   PubMed Web of Science ®Google Scholar
• Holloway JW, Yang IA, Holgate ST. (2010). Genetics of allergic disease. J Allergy Clin Immunol 125:S81–94
   PubMed Web of Science ®Google Scholar
• Jung DJ, Porzel A, Huneck S. (1991). Gigasol and other coumarins from Angelica gigas. Phytochemistry 30:710–12
   Web of Science ®Google Scholar
• Kansy M, Senner F, Gubernator K. (1998). Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 41:1007–10
   PubMed Web of Science ®Google Scholar
• Kerns EH. (2001). High throughput physicochemical profiling for drug discovery. J Pharm Sci 90:1838–58
   PubMed Web of Science ®Google Scholar
• Krzyzanski W, Jusko WJ. (1998). Characterization of pharmacodynamic recession slopes for direct and indirect response models. J Pharmacokinet Biopharm 26:409–36
   PubMedGoogle Scholar
• Lee J, Bielory L. (2010). Complementary and alternative interventions in atopic dermatitis. Immunol Allergy Clin North Am 30:411–24
   PubMed Web of Science ®Google Scholar
• Lee JH, Choi YS, Kim JH, et al. (2006). A mass preparation method of (+)-decursinol from the roots of Angelica gigas. J Pharm Soc Korea 50:338–44
   Google Scholar
• Lee JS, Kim IS, Ryu JS, et al. (2011). The inhibitory effect of Duchesnea chrysantha extract on the development of atopic dermatitis-like lesions by regulating IgE and cytokine production in Nc/Nga mice. Phytother Res 26:284–90
   PubMedGoogle Scholar
• Lehr T, Staab A, Tillmann C, et al. (2009). A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam. Clin Pharmacokinet 48:529–42
   PubMed Web of Science ®Google Scholar
• Lipinski CA. (2000). Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235–49
   PubMed Web of Science ®Google Scholar
• Matsuda H, Watanabe N, Geba GP, et al. (1997). Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9:461–6
   PubMed Web of Science ®Google Scholar
• McGonigle P, Ruggeri B. (2014). Animal models of human disease: challenges in enabling translation. Biochem Pharmacol 87:162–71
   PubMed Web of Science ®Google Scholar
• Novak N. (2009). New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy 64:265–75
   PubMed Web of Science ®Google Scholar
• Novak N, Simon D. (2011). Atopic dermatitis – from new pathophysiologic insights to individualized therapy. Allergy 66:830–9
   PubMed Web of Science ®Google Scholar
• Okusanya O, Forrest A, DiFrancesco R, et al. (2007). Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother 51:1822–6
   PubMed Web of Science ®Google Scholar
• Plötz SG, Ring J. (2010). What's new in atopic eczema? Expert Opin Emerg Drugs 15:249–67
   PubMed Web of Science ®Google Scholar
• Sheiner LB, Stanski DR, Vozeh S, et al. (1979). Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 25:358–71
   PubMed Web of Science ®Google Scholar
• Smith DA, Di L, Kerns EH. (2010). The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov 9:929–39
   PubMed Web of Science ®Google Scholar
• Son CY, Baek IH, Song GY, et al. (2009). Pharmacological effect of decursin and decursinol angelate from Angelica gigas Nakai. J Pharm Soc Korea 53:303–13
   Google Scholar
• Song JS, Chae JW, Lee KR, et al. (2011). Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats. Xenobiotica 41:895–902
   PubMed Web of Science ®Google Scholar
• Ständer S, Luger TA. (2010). Itch in atopic dermatitis – pathophysiology and treatment. Acta Dermatovenerol Croat 18:289–96
   PubMed Web of Science ®Google Scholar
• Strachan DP. (1999). Lifestyle and atopy. Lancet 353:1457–8
   PubMedGoogle Scholar
• Stuart M, Box K. (2005). Chasing equilibrium: measuring the intrinsic solubility of weak acids and bases. Anal Chem 77:983–90
   PubMed Web of Science ®Google Scholar
• Suto H, Matsuda H, Mitsuishi K, et al. (1999). NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 120:70–5
   PubMedGoogle Scholar
• Svensson A, Chambers C, Gånemo A, Mitchell SA. (2011). A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis. Curr Med Res Opin 27:1395–406
   PubMed Web of Science ®Google Scholar
• Wang Y, Roy A, Sun L, Lau CE. (1999). A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration. Drug Metab Dispos 27:855–9
   PubMed Web of Science ®Google Scholar
• Xu R, Nemes C, Jenkins KM, et al. (2002). Application of parallel liquid chromatography/mass spectrometry for high-throughput microsomal stability screening of compound libraries. J Am Soc Mass Spectrom 13:155–65
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Mizutani H. (2011). The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. Curr Probl Dermatol 41:80–92
   PubMedGoogle Scholar
• Yang EJ, Song GY, Lee JS, et al. (2009). A novel (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]chromen-3-yl-ester, inhibits ovalbumin-induced lung inflammation in a mouse model of asthma. Biol Pharm Bull 32:444–9
   PubMedGoogle Scholar
• Yee S. (1997). In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man—fact or myth. Pharm Res 14:763–6
   PubMed Web of Science ®Google Scholar